Printable Schedule-at-a-Glance (Last updated: 10/20/16)


5:00–7:00 p.m.

Welcome Reception (Provided)

7:00–8:30 p.m.

Group Dinner (Provided)

THURSDAY, NOV. 3, 2016 — Up to 6.5 continuing education credits available ACPE UAN 0860-0000-16-005-L01-P/0860-0000-16-005-L01-T

      7:00 a.m.

Registration and Continental Breakfast

      8:00 a.m.

Welcome and Opening Remarks

      8:30 a.m.

Keynote Address — Lifestyle Is the Medicine: What's the Spoon? David L. Katz, MD, MPH, FACPM, FACP, Founding Director, Yale University's Yale-Griffin Prevention Research Center; President, American College of Lifestyle Medicine

This talk will first examine what the impact of diet and lifestyle COULD BE on the human condition if knowledge were power. It will then consider the toll associated with our failure to use what we know. The talk will then look closely at the body of evidence relating dietary patterns to human health — and make the case that we are NOT clueless about the basic care and feeding of our species. Endless debate about the details of optimal diets, and an insatiable pop culture fascination with scapegoats and silver bullets — distract us from the well-known fundamentals of healthful eating, and forestall the stunning advances in public health that would ensue were we to turn what we know into what we do. The case will be made that lifestyle is the best, most readily available medicine; and culture could be the spoon that helps it go down.

Learning Objectives:

  1. Characterize recent trends in obesity and diabetes.
  2. Identify the root causes of epidemic obesity and chronic disease.
  3. Quantify the potential impact of lifestyle behaviors on the incidence of chronic disease.
  4. Identify specific programs that show promise in reversing the trends in obesity and related conditions.

      9:30 a.m.


      9:45 a.m.

Telemedicine: Is This the Next Real Innovation in Health Care Delivery?
Distinguished Guest Speaker Reed V. Tuckson, MD, FACP, Managing Director, Tuckson Health Connections, LLC; Chairman, Board of Directors, ViTel Net, LLC; Immediate Past President and Board Member, American Telemedicine Association

Telemedicine has continued to grow as a unique way of delivering care to patients, while greatly improving access, reducing cost and positively impacting quality. Despite this staggering increase in users, there are still some barriers preventing its widespread use including technological, financial, and legal obstacles. Dr. Tuckson will discuss current challenges of integrating telemedicine into health care systems and the potential impact of telemedicine on improving health care quality, access, equity, and affordability.

Learning Objectives:

  1. Describe barriers to integrating telemedicine into health care systems and to its widespread clinical application.
  2. Discuss the positive impact of telemedicine on health care quality, access, equity and affordability.
  3. Review ambulatory applications of new telemedicine modalities, including wearable technologies, to improve health.

    10:45 a.m.

Ethics: First Human Trials and Genetic Screening Coverage, Jeffrey P. Kahn, PhD, MPH, Andreas C. Dracopoulos Director, Johns Hopkins Berman Institute of Bioethics

Mitochondrial pathogenic DNA mutations are responsible for pathological mutations in one out of 5,550 live births, and there are few effective treatment options for people living with these genetic diseases. Consequently, scientists have been developing interventions such as mitochondrial replacement technologies (MRT) whereby mitochondrial DNA (mtDNA) from a healthy donor is used to replace mutated host mtDNA in order to create an embryo that would result in an offspring who would not suffer from mtDNA diseases. Genomic medicine such as this has the capacity to revolutionize clinical practice. However, these rapidly emerging technologies are ethically fraught and lead to concerns about risks and uncertainty for potential offspring created through these techniques, for the donors and prospective parents involved, and for society. In addition, regulators must identify steps for review and approval of such novel reproductive technologies, and payers must determine appropriate approaches for reimbursement decisions — all complicated by limited data on which to make assessments.

During this presentation, Dr. Kahn will describe the issues associated with these new technologies and explore the ethical and policy concerns associated with these rapidly developing biotechnological interventions.

Learning Objectives:

  1. Explain the potential for genomic medicine and its role in clinical practice, through the case of MRT.
  2. Discuss current ethical and regulatory concerns associated with initial investigations and eventual introduction of novel reproductive technologies.
  3. Describe and discuss the issues and concerns associated with health insurance coverage for experimental treatments and novel reproductive technologies.

    11:45 a.m.

Lunch and Exhibits (Lunch provided)

      1:15 p.m.

Providing High Quality Health Care Experiences for Individuals With Intellectual and Developmental Disabilities (IDD), Lynne Tomasa, MSW, PhD, Assistant Professor, Family and Community Medicine, University of Arizona College of Medicine

Learning Objectives:

  1. Review the current state of knowledge regarding aging and intellectual disabilities, life-long caregiving, and planning for the future.
  2. Identify how research can inform best practices that support quality of life and quality care for persons with IDD.
  3. Understand the role of health care providers and service systems in supporting self-advocacy and inclusion.



      2:15 p.m.

The Fight Against the Prescription Opioid Abuse Epidemic, Mark D. Sullivan, MD, PhD, UW Medicine

According to the Centers for Disease Control, between 2000 and 2014, the drug epidemic in the United States claimed the lives of half a million people, with 2014 being the most lethal year on record. Of the 28,000 deaths caused by drug overdose in 2014, more than 60 percent were due to an opioid overdose. The goal of this presentation is to explain how health care providers can identify the signs of drug toxicity and understand the risks of opioid use and abuse in their patient population, in addition to learning how to create pain-management plans that do not require opioids for their chronic-pain patients. It will also explain important steps taken by governments and administrations in addressing the prescription opioid abuse epidemic.

Learning Objectives:

  1. Describe how governments and administrations are addressing the prescription opioid abuse epidemic.
  2. Discuss how physicians, pharmacists and other health care professionals can incorporate risk-reduction strategies for pain management.
  3. State ways in which members of the interprofessional team can effectively evaluate patients with chronic and acute pain conditions, identify non-opioid treatment strategies, and learn how to safely manage patients who require opioid treatment.

      3:15 p.m.


      3:30 p.m.

Correct Diagnosis and Optimal Management of Migraines, Robert G. Kaniecki, MD, Director, Headache Center; Chief, Headache Division; Assistant Director, Neurology Residency Training Program; Director, Headache Fellowship Program; Assistant Professor, Neurology; Department of Neurology at University of Pittsburgh School of Medicine

Migraine is a common disabling primary headache disorder that affects an estimated 36 million Americans. The correct diagnosis of a headache is necessary in order to begin an effective treatment plan — in one recent study, 72 percent of primary care providers were either not aware or minimally aware of national guidelines for the management of migraine headaches The primary goals of migraine treatment include relieving pain, restoring function, and reducing headache frequency; an additional goal may be preventing progression to chronic migraine. Dr. Kaniecki will discuss the importance of a correct diagnosis, multidisciplinary strategies for the management and prevention of chronic migraine, and the various factors influencing migraine.

Learning Objectives:

  1. Describe the disease course, clinical features, and factors that influence chronic migraines and the importance of making a correct diagnosis.
  2. State current diagnostic criteria, national guidelines and new methodologies for the management of migraine headaches.
  3. Discuss evidence-based multidisciplinary strategies for the management and prevention of chronic migraine.

4:15–5:00 p.m.

Chronic Back Pain Management: What’s New in Treatment Options for this Population? Franz J. Macedo, DO, Medical Director, Comprehensive Pain Center, Minneapolis Veterans Affairs Health Care System; Program Director, Pain Medicine Fellowship, University of Minnesota

It is estimated that 80 percent of Americans will experience some type of back pain within their lifetime. Although guidelines exist for managing back pain, studies suggest that health care providers are not implementing the guidelines. Patients may be treated for acute back pain that will resolve quickly with no residual loss of function. On the other hand, 20 percent of these patients will have chronic back pain that will last greater than 12 weeks. Chronic back pain may be due to a diagnosable anatomical cause or from no clearly identifiable explanation. The treatment for chronic back pain may include a variety of interventions, such as medications, narcotics, nerve-block injections, physical therapy or surgery. During this session, Dr. Macedo will discuss new advancements and solutions for successful management of chronic back pain.

Learning Objectives:

  1. Distinguish the difference between acute and chronic back pain.
  2. Discuss the challenges providers and patients face when dealing with chronic back pain.
  3. Review new methodologies and non-opioid treatment strategies for managing chronic back pain.

5:00–7:00 p.m.

Reception and Exhibits (Reception provided)

Note: OptumHealth Education reserves the right to make any necessary changes to this program. Efforts will be made to keep presentations as scheduled. However, unforeseen circumstances may result in the substitution of faculty or content.
Last Updated: 10/20/2016